Profile data is unavailable for this security.
About the company
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. It also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.
- Revenue in USD (TTM)11.20m
- Net income in USD-16.44m
- Incorporated2010
- Employees24.00
- LocationNovaBay Pharmaceuticals Inc2000 Powell St Ste 1150EMERYVILLE 94608-1804United StatesUSA
- Phone+1 (510) 899-8800
- Fax+1 (510) 225-0371
- Websitehttps://novabay.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CYANOTECH CORP | 23.30m | -5.45m | 2.65m | 77.00 | -- | 0.2727 | -- | 0.1137 | -0.7939 | -0.7939 | 3.40 | 1.36 | 0.896 | 2.15 | 15.42 | 302,532.50 | -20.98 | -3.46 | -32.30 | -4.46 | 22.66 | 34.54 | -23.41 | -3.58 | 0.307 | -7.00 | 0.42 | -- | -0.4616 | -5.24 | -53.11 | -- | -6.42 | -- |
| Universe Pharmaceuticals Inc | 26.73m | -18.55m | 2.82m | 225.00 | -- | 0.0163 | -- | 0.1056 | -76.44 | -76.44 | 110.26 | 110.02 | 0.4462 | 6.13 | 1.68 | 118,781.90 | -30.97 | 5.31 | -48.85 | 7.07 | 28.27 | 46.26 | -69.40 | 6.25 | 1.46 | -0.6939 | 0.1958 | 0.00 | -19.52 | 2.53 | 29.46 | -- | -21.17 | -- |
| Scorpius Holdings Inc | 10.04m | -29.66m | 2.86m | 82.00 | -- | 0.0813 | -- | 0.2846 | -107.62 | -101.17 | 5.25 | 8.12 | 0.1725 | -- | 16.55 | 122,491.30 | -53.23 | -39.37 | -69.92 | -43.18 | 61.92 | -- | -308.58 | -1,068.21 | 0.6007 | -27.31 | 0.3146 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
| Processa Pharmaceuticals Inc | 0.00 | -11.53m | 2.87m | 13.00 | -- | 0.7727 | -- | -- | -4.86 | -4.86 | 0.00 | 1.14 | 0.00 | -- | -- | 0.00 | -176.99 | -84.35 | -209.96 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0022 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 2.98m | -- | -- | -- | 1.97 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| Scisparc Ltd | 0.00 | -6.96m | 2.99m | 3.00 | -- | 8.40 | -- | -- | -1.22 | -1.51 | 0.00 | 0.0344 | 0.00 | -- | -- | 0.00 | -92.51 | -69.39 | -152.41 | -111.07 | -- | -- | -- | -527.17 | -- | -- | 0.9371 | -- | 113.73 | -- | -97.61 | -- | -- | -- |
| China Pharma Holdings Inc | 5.54m | -4.74m | 3.42m | 231.00 | -- | 0.5444 | -- | 0.616 | -0.3958 | -0.3958 | 0.4119 | 0.3655 | 0.3848 | 2.38 | 15.81 | 24,002.68 | -32.92 | -29.66 | -55.81 | -55.25 | -34.34 | 6.47 | -85.56 | -73.09 | 0.2605 | -27.44 | 0.377 | -- | -13.48 | -10.68 | 22.50 | -- | -25.78 | -- |
| NovaBay Pharmaceuticals Inc | 11.20m | -16.44m | 3.52m | 24.00 | -- | 3.30 | -- | 0.314 | -53.22 | -53.40 | 7.77 | 0.2195 | 1.34 | 2.22 | 13.83 | 466,625.00 | -119.49 | -61.51 | -196.48 | -83.89 | 60.67 | 59.99 | -89.25 | -86.47 | 0.9103 | -- | 0.0454 | -- | 2.24 | 3.32 | -2.66 | -- | -15.46 | -- |
| Titan Pharmaceuticals Inc | 4.00k | -5.46m | 3.59m | 4.00 | -- | 0.8998 | -- | 898.23 | -6.59 | -6.59 | 0.0049 | 4.37 | 0.0016 | -- | 0.1702 | 1,000.00 | -211.58 | -96.80 | -368.99 | -156.65 | -- | -- | -136,525.00 | -406.26 | -- | -309.96 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Sonoma Pharmaceuticals Inc | 13.55m | -3.69m | 3.90m | 172.00 | -- | 0.7278 | -- | 0.2877 | -4.91 | -4.91 | 16.95 | 4.00 | 0.9917 | 3.11 | 5.04 | 78,761.63 | -26.98 | -29.36 | -35.49 | -40.65 | 38.52 | 38.00 | -27.21 | -30.93 | 2.84 | -- | 0.0151 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
| Silo Pharma Inc | 72.12k | -3.71m | 4.08m | 3.00 | -- | 0.6017 | -- | 56.58 | -1.16 | -1.19 | 0.022 | 1.51 | 0.0082 | -- | -- | 24,040.00 | -42.31 | -24.90 | -46.92 | -26.39 | 91.90 | 82.79 | -5,149.53 | -2,757.85 | -- | -- | 0.00 | -- | 0.00 | -- | 7.07 | -- | -- | -- |
| Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 4.16m | -- | 0.0232 | 0.005 | 1.14 | 0.3906 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Biofrontera Inc | 35.36m | -12.84m | 4.21m | 85.00 | -- | 0.8962 | -- | 0.119 | -1.63 | -1.63 | 8.82 | 0.8469 | 1.34 | 1.66 | 6.21 | 415,988.30 | -48.79 | -- | -205.99 | -- | 47.11 | -- | -36.30 | -- | 0.9432 | -6.43 | 0.00 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
| Sunshine Biopharma Inc | 32.96m | -4.23m | 4.24m | 44.00 | -- | 0.1694 | -- | 0.1286 | -144.23 | -144.23 | 95.92 | 12.52 | 1.14 | 3.18 | 12.55 | 749,079.60 | -14.65 | -101.52 | -17.57 | -137.04 | 30.78 | 35.47 | -12.82 | -165.33 | 3.57 | -- | 0.00 | -- | 454.42 | -- | 83.15 | -- | 110.99 | -- |
Data as of Nov 22 2024. Currency figures normalised to NovaBay Pharmaceuticals Inc's reporting currency: US Dollar USD
2.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| C2C Wealth Management LLCas of 30 Sep 2024 | 42.95k | 0.88% |
| Geode Capital Management LLCas of 30 Sep 2024 | 26.34k | 0.54% |
| UBS Securities LLCas of 30 Sep 2024 | 21.06k | 0.43% |
| Warberg Asset Management LLCas of 30 Sep 2024 | 10.00k | 0.21% |
| Tower Research Capital LLCas of 30 Sep 2024 | 5.48k | 0.11% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Sep 2024 | 503.00 | 0.01% |
| Bank of America, NA (Private Banking)as of 30 Sep 2024 | 42.00 | 0.00% |
| NVWM LLCas of 30 Sep 2024 | 3.00 | 0.00% |
| Thrivent Trust Co.as of 30 Sep 2024 | 2.00 | 0.00% |
| RBC Dominion Securities, Inc. (Investment Management)as of 30 Sep 2024 | 1.00 | 0.00% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
